Stay updated on Tepotinib Phase II Clinical Trial
Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.
Latest updates to the Tepotinib Phase II Clinical Trial page
- Check4 days agoChange DetectedEU CTIS number 2024-512003-39-00 was added and recruitment locations were expanded to 176 sites across the US and Europe. The page revision notes version v3.3.3 and updates to location details.SummaryDifference1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded clarifying text about the Publications section: some publications are provided voluntarily and relate to the results, while others are automatically filled from PubMed. Revision: v3.3.2.SummaryDifference0.1%
- Check40 days agoChange DetectedDeleted a general government funding and operating status notice that previously appeared on the page; it did not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check54 days agoChange DetectedSubstantive content did not change; the two screenshots show the same Study Details page for NCT02864992 with no additions or deletions to the core content.SummaryDifference0.2%
- Check83 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%
- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%
Stay in the know with updates to Tepotinib Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.